home / stock / axnx / axnx news


AXNX News and Press, Axonics Modulation Technologies Inc. From 08/14/23

Stock Information

Company Name: Axonics Modulation Technologies Inc.
Stock Symbol: AXNX
Market: NASDAQ
Website: axonics.com

Menu

AXNX AXNX Quote AXNX Short AXNX News AXNX Articles AXNX Message Board
Get AXNX Alerts

News, Short Squeeze, Breakout and More Instantly...

AXNX - August MDA Breakout Stocks Week 33 - 2023: Facing The Largest Negative Signal Since February

2023-08-14 15:22:00 ET Summary Two new Breakout Stocks for Week 33 curated by the MDA model for 10% short-term upside along with one Dow pick. Last week two of four picks gained over the 10% mark in less than a week with peak gains in EHTH +12.3% and ATEX +15.4% still near highs. ...

AXNX - Axonics: Rapid Growth But Waiting For Profitability

2023-07-29 00:22:52 ET Summary Axonics Inc. has grown its valuation to $2.7 billion in the healthcare equipment industry. The company focuses on developing products for the treatment of bladder and bowel dysfunctions. Recent developments include acquiring technology for easier...

AXNX - Why Shares of Axonics Rose Friday

2023-07-28 12:46:30 ET Shares of Axonics (NASDAQ: AXNX) were up more than 10% at noon on Friday after the medical device company released second-quarter earnings. The healthcare stock is down more than 6% so far this year. Axonics focuses on medical products to treat bladder...

AXNX - Axonics, Inc. (AXNX) Q2 2023 Earnings Call Transcript

2023-07-27 23:27:09 ET Axonics, Inc. (AXNX) Q2 2023 Earnings Conference Call July 27, 2023 16:30 ET Company Participants Neil Bhalodkar - Vice President of Investor Relations Raymond Cohen - Chief Executive Officer Dan Dearen - President & Chief Financial Off...

AXNX - Axonics Modulation Technologies GAAP EPS of -$0.15, revenue of $92.9M

2023-07-27 16:14:52 ET Axonics Modulation Technologies press release ( NASDAQ: AXNX ): Q2 GAAP EPS of -$0.15. Revenue of $92.9M. Sees 2023 total company revenue of $358 million, an increase of 31% compared to fiscal year 2022. For further details see: Axonics...

AXNX - Axonics Reports Second Quarter 2023 Financial Results

Generated quarterly revenue of $92.9 million, an increase of 35% year over year Fiscal year 2023 revenue guidance increased to $358 million Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment o...

AXNX - Axonics Modulation Technologies Q2 2023 Earnings Preview

2023-07-26 17:35:57 ET Axonics Modulation Technologies ( NASDAQ: AXNX ) is scheduled to announce Q2 earnings results on Thursday, July 27th, after market close. The consensus EPS Estimate is -$0.09 (+80.9% Y/Y) and the consensus Revenue Estimate is $86.26M (+25.0% Y/Y). ...

AXNX - July MDA Breakout Stocks Week 29 - 2023: High-Frequency Gainers To Give You An Edge

2023-07-17 05:36:22 ET Summary Two new Breakout Stocks for Week 29 with better than 10% short-term upside and a Dow 30 Pick. Average cumulative returns for 2023 are at +126.4% YTD. Last week 3 out of 4 picks gained over 13.4% with peak gains in KODK +23.8%, SMCI +19.2%, YMM +13.4%...

AXNX - Axonics, Shockwave Medical move in response to Medicare proposals

2023-07-14 11:54:56 ET Axonics, ( NASDAQ: AXNX ) and Shockwave Medical ( NASDAQ: SWAV ) moved in opposite directions Friday after the Centers for Medicare & Medicaid Services (CMS) proposed changes to 2024 Medicare reimbursement rates for hospital outpatient department...

AXNX - Axonics to Report Second Quarter 2023 Financial Results on July 27

Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, will report second quarter 2023 financial results after the close of trading on Thursday, July 27. Axonics will host a co...

Previous 10 Next 10